U.S., Nov. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07909811) titled 'Novel endOvascular Therapy With beVAcizumab and Cannabinoids for Glioblastoma' on Oct. 26.
Brief Summary: The goal of this clinical trial is to learn if a combined treatment of bevacizumab delivered directly to the brain tumour and a cannabis-based oral spray (nabiximols) can be given safely and practically alongside standard radiation and chemotherapy in adults with newly diagnosed glioblastoma. The main questions it aims to answer are:
How many participants have serious side effects (regimen-limiting toxicities) from the combined treatment? Can participants receive and complete the planned treatment, and how often does the cathete...